López-Rubio Marina, Lago-Rodríguez Marta-Olimpia, Ordieres-Ortega Lucía, Oblitas Crhistian-Mario, Moragón-Ledesma Sergio, Alonso-Beato Rubén, Alvarez-Sala-Walther Luis-Antonio, Galeano-Valle Francisco
Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
J Clin Med. 2024 Dec 21;13(24):7818. doi: 10.3390/jcm13247818.
Catheter-related thrombosis (CRT) is a frequent and potentially serious complication associated with the widespread use of intravascular devices such as central venous catheters, including peripherally inserted central catheters and implantable port systems, pacemakers or implantable cardioverter-defibrillators. Although CRT management has been informed by guidelines extrapolated from lower extremity deep vein thrombosis (DVT), unique challenges remain due to the distinct anatomical, pathophysiological, and clinical characteristics of upper extremity DVT. Risk factors for CRT are multifactorial, encompassing patient-related characteristics such as cancer, prior venous thromboembolism, and infection, as well as catheter-specific factors like device type, lumens, and insertion site. The diagnosis of CRT relies primarily on ultrasonography; however, computed tomography angiography and magnetic resonance imaging play a complementary role, particularly in anatomically challenging cases or when complications such as pulmonary embolism or superior vena cava syndrome are suspected. Treatment strategies for CRT include anticoagulation, catheter removal when feasible, and, in select cases, local thrombolysis or catheter-directed interventions. Anticoagulation remains the cornerstone of therapy, with direct oral anticoagulants increasingly favored due to their safety profile and efficacy. This article provides a detailed review of CRT, focusing on clinical features, diagnostic methods, and treatment strategies while addressing specific challenges in managing pacemaker and hemodialysis catheter-related thrombosis.
导管相关血栓形成(CRT)是一种常见且可能严重的并发症,与中心静脉导管等血管内装置的广泛使用相关,这些装置包括外周静脉置入中心静脉导管、植入式输液港系统、起搏器或植入式心脏复律除颤器。尽管CRT的管理已参考从下肢深静脉血栓形成(DVT)外推而来的指南,但由于上肢DVT独特的解剖、病理生理和临床特征,仍然存在独特的挑战。CRT的危险因素是多因素的,包括与患者相关的特征,如癌症、既往静脉血栓栓塞和感染,以及与导管相关的因素,如装置类型、管腔和插入部位。CRT的诊断主要依靠超声检查;然而,计算机断层血管造影和磁共振成像起辅助作用,特别是在解剖结构复杂的病例或怀疑有肺栓塞或上腔静脉综合征等并发症时。CRT的治疗策略包括抗凝、在可行时拔除导管,以及在特定情况下进行局部溶栓或导管定向干预。抗凝仍然是治疗的基石,由于其安全性和有效性,直接口服抗凝剂越来越受到青睐。本文对CRT进行了详细综述,重点关注临床特征、诊断方法和治疗策略,同时探讨了起搏器和血液透析导管相关血栓形成管理中的特定挑战。